Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDRH Focuses Bioresearch Inspections On Sponsor Monitoring In FY 99

This article was originally published in The Gray Sheet

Executive Summary

Inadequate monitoring of clinical trial sites was found in over 50% of inspections of device study sponsors in fiscal year 1999, Charma Konnor, director of the Division of Bioresearch Monitoring within the Center for Devices and Radiological Health told attendees at a Dec. 16 session of the Food & Drug Law Educational Conference in Washington, D.C.

You may also be interested in...

BIMO Warnings Increase In Fiscal 2000, Sponsor Monitoring Problems Fewer

FDA's Center for Devices and Radiological Health bioresearch monitoring division (BIMO) issued 23 warning letters and 137 untitled letters as of August FY 2000, a roughly 27% increase in each category compared with the full 12-month period of FY 1999.

COVID-19 Vaccine 'Brexit Bonus' A Myth

The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts